State Street Corp Rocket Pharmaceuticals, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 3,102,022 shares of RCKT stock, worth $35.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,102,022

Previous 2,779,866 11.59%

Holding current value

$35.9 Million

Previous $59.9 Million 4.27%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.6 - $25.88 $5.67 Million - $8.34 Million	322,156 Added 11.59%	3,102,022 $57.3 Million
Q2 2024 Aug 14, 2024	SELL	$20.66 - $26.72 $29.2 Million - $37.8 Million	-1,413,211 Reduced 33.7%	2,779,866 $59.9 Million
Q1 2024 May 15, 2024	BUY	$26.16 - $30.74 $25.2 Million - $29.6 Million	961,666 Added 29.76%	4,193,077 $113 Million
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $1.54 Million - $2.94 Million	91,906 Added 2.93%	3,231,411 $96.8 Million
Q3 2023 Nov 14, 2023	SELL	$15.07 - $24.05 $588,016 - $938,406	-39,019 Reduced 1.23%	3,139,505 $64.3 Million
Q2 2023 Aug 14, 2023	SELL	$16.59 - $23.6 $14 Million - $19.9 Million	-841,162 Reduced 20.93%	3,178,524 $63.2 Million
Q1 2023 May 15, 2023	BUY	$15.79 - $22.6 $642,668 - $919,842	40,701 Added 1.02%	4,019,686 $68.9 Million
Q4 2022 Feb 14, 2023	BUY	$15.5 - $22.76 $9.09 Million - $13.4 Million	586,652 Added 17.29%	3,978,985 $77.9 Million
Q3 2022 Nov 15, 2022	BUY	$12.37 - $18.41 $10.6 Million - $15.8 Million	856,076 Added 33.75%	3,392,333 $54.1 Million
Q2 2022 Aug 15, 2022	SELL	$7.96 - $16.64 $1.73 Million - $3.62 Million	-217,390 Reduced 7.89%	2,536,257 $34.9 Million
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $5.4 Million - $9.71 Million	410,234 Added 17.51%	2,753,647 $43.7 Million
Q4 2021 Feb 14, 2022	BUY	$21.52 - $36.02 $74,868 - $125,313	3,479 Added 0.15%	2,343,413 $51.2 Million
Q3 2021 Nov 15, 2021	BUY	$27.42 - $48.97 $15.9 Million - $28.4 Million	579,034 Added 32.88%	2,339,934 $69.9 Million
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $5.83 Million - $6.98 Million	147,812 Added 9.16%	1,760,900 $78 Million
Q1 2021 May 17, 2021	BUY	$43.34 - $65.91 $19.8 Million - $30.1 Million	457,043 Added 39.54%	1,613,088 $71.6 Million
Q4 2020 Feb 16, 2021	SELL	$23.3 - $59.57 $11.1 Million - $28.4 Million	-477,010 Reduced 29.21%	1,156,045 $63.4 Million
Q3 2020 Nov 10, 2020	BUY	$20.5 - $28.59 $915,653 - $1.28 Million	44,666 Added 2.81%	1,633,055 $37.3 Million
Q2 2020 Aug 14, 2020	BUY	$13.32 - $22.61 $8.29 Million - $14.1 Million	622,674 Added 64.48%	1,588,389 $33.2 Million
Q1 2020 May 11, 2020	BUY	$9.71 - $25.11 $9.38 Million - $24.2 Million	965,715 New	965,715 $13.5 Million

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $875M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Rocket Pharmaceuticals, Inc. Transaction History